Introduction: Some studies suggest an association between interferon beta (IFNβ) therapies and the development of depression symptoms in multiple sclerosis (MS). This study aimed to evaluate the impact of baseline depression (BLD) on depression score variation at 24 months (m) in MS patients starting treatment with IFNβ-1a. Methods: Multicenter, prospective, observational study in patients recently diagnosed wi...
To date, no neuroprotective/disease-modifying strategy has been approved as a Parkinson’s Disease (PD) therapy, because of the‘one-disease-one-target’ view that has been followed. New drug-based therapeutic routes, namely Safinamide, have been introduced as a promising multimodal drug combining dopaminergic and non-dopaminergic (neuroprotective) actions, representing a new potential alternative therapy to preve...
1624-1632 p.; Submitted by Adriene Marchiori (adrienemarchiori@yahoo.com.br) on 2017-06-07T12:50:52Z No. of bitstreams: 1 Artigo_ANPPOM_2012_2_MoacyrCostaFilho.pdf: 196173 bytes, checksum: f2c02b8eeae6c0cec4d5ab4517d3eb11 (MD5); Approved for entry into archive by Nilson Nascimento Souza (nilson@ufba.br) on 2017-07-24T11:09:11Z (GMT) No. of bitstreams: 1 Artigo_ANPPOM_2012_2_MoacyrCostaFilho.pdf: 196173 bytes, c...
[Excerpt] Hard tissue damage and loss caused by mechanical trauma, degenerative diseases, infections, tumors, and other diseases exert a profound negative impact on patients’ quality of life and impose a heavy social and economic burden. Currently, tissue engineering is believed to be a promising approach to recover the structural integrity and function of these damaged or diseased hard tissues.[...]
Introduction/Aims: Osteogenesis imperfecta (OI) is a genetic disorder characterized by bone fragility and osteopenia. Treatment involves a multidisciplinary approach and aims to improve the quality of life. The authors aimed to describe the characteristics of a sample of children with OI, to evaluate the treatment and clinical outcome before and after therapy. Material and Methods: An observational, longitudina...
Patients with systemic lupus erythematosus (SLE) can develop dysfunction of the central nervous system (CNS) and have several neurologic syndromes with heterogeneous pathogenic mechanisms. The most common neurologic manifestations of SLE are organic mental syndromes, functional psychoses and seizures.We retrospectively reviewed the magnetic resonance imaging (MRI) of SLE patients with CNS involvement followed i...